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Introduction
Ribosomes are universal cellular machines that decode mRNA 
in a vectorial manner to synthesize proteins. During translation, 
the nascent polypeptide chain moves from the peptidyl-trans-
ferase center through the exit tunnel to the exit site, located at 
the surface of the large ribosomal subunit (Nissen et al., 2000). 
There, the nascent chain emerges from the ribosome and en-
gages a suite of protein biogenesis factors, which cotransla-
tionally regulate enzymatic processing, folding, and subcellular 
targeting of the newly made protein (Preissler and Deuerling, 
2012; Gloge et al., 2014). The ribosome itself acts as a binding 
platform for these factors, positioning them for optimal inter-
action with the nascent chain. Different nascent chains interact 
with distinct factors, and several of these factors appear to have 
potentially overlapping binding sites on the ribosome, hence 
careful regulation of their binding is required for efficient pro-
tein biogenesis (Leidig et al., 2013; Pechmann et al., 2013).
The mechanism of translation initiation dictates that all 
proteins possess a methionine as the first amino acid residue. For 
the majority of cytosolic proteins, this methionine is removed 
cotranslationally by the enzyme MetAP (Jackson and Hunter, 
1970). However, not all proteins are substrates for MetAP; only 
those with a small amino acid side chain at the second (P2) res-
idue have their methionine cleaved (Huang et al., 1987; Boissel 
et al., 1988). After methionine removal, the exposed P2 resi-
due can be further processed by either N-myristoyl or N-acetyl 
transferases (Martinez et al., 2008; Starheim et al., 2012).
Eukaryotes possess two distinct cytosolic MetAPs with 
overlapping specificity (Li and Chang, 1995). In yeast, simulta-
neous deletion of both isoforms is lethal, indicating an essential 
role for MetAP (Li and Chang, 1995).
Secretory proteins possess hydrophobic signal sequences 
that are recognized cotranslationally by SRP (Akopian et al., 
2013; Nyathi et al., 2013). Eukaryotic SRP is a ribonucleo-
protein particle composed of six proteins and the SRP RNA. 
SRP binds to the ribosome at the exit site, such that the SRP54 
protein, which binds the signal sequence, contacts ribosomal 
proteins Rpl25 and Rpl35 (uL23 and uL29, respectively, ac-
cording to new nomenclature; Ban et al., 2014), as well as ele-
ments of the 26S rRNA (Halic et al., 2004). SRP54 is optimally 
positioned to bind a signal sequence as it emerges from the 
ribosome. Multiple nascent chain-binding factors also contact 
Rpl25/35, hence it has been termed the universal adaptor site 
(UAS; Halic and Beckmann, 2005).
Once bound to SRP, the ribosome-nascent chain (RNC)–
SRP complex is targeted to the ER membrane via the interac-
tion of SRP with its membrane-associated SRP receptor (SR; 
Gilmore et al., 1982). SR catalyzes the transfer of the RNC 
from SRP to the Sec61 complex. Sec61 also binds to the ribo-
some at the exit site, such that the exit tunnel and the pore of the 
Sec61 channel are coaligned (Becker et al., 2009; Voorhees et 
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al., 2014). Thus, as the nascent chain extends, it moves through 
the pore of the Sec61 channel into the ER lumen.
In addition to SRP and MetAP, the nascent polypep-
tide-associated complex (NAC) also binds close to the exit site 
where it contacts nascent chains (Wegrzyn et al., 2006; Pech et 
al., 2010; Zhang et al., 2012). In yeast, NAC exists predomi-
nantly as a heterodimer of αNAC (Egd2) and βNAC (Egd1; Rei-
mann et al., 1999), although homodimers of Egd2 and the minor 
βNAC homologue Btt1 have been reported (Panasenko et al., 
2006; del Alamo et al., 2011). NAC has been proposed to play a 
role in regulating the specificity of SRP substrate binding (Pow-
ers and Walter, 1996; del Alamo et al., 2011) and in the delivery 
of the nascent chain to SRP in vitro (Zhang et al., 2012). How-
ever, direct evidence for a role of NAC in ER targeting in vivo is 
presently lacking. NAC was also shown to collaborate with the 
ribosome-bound Hsp70, Ssb1/2 in the biogenesis of ribosomal 
proteins and biogenesis factors (Koplin et al., 2010). Moreover, 
a role for NAC in proteostasis and a chaperone-like function is 
supported by recent studies (Kirstein-Miles et al., 2013).
NAC was shown to interact with very short nascent chains 
as they emerge from the ribosome (Wiedmann et al., 1994; Jun-
gnickel and Rapoport, 1995). SRP is recruited to the ribosome 
at nascent chain length of ∼30 residues (Berndt et al., 2009). 
Similarly, MetAP also acts on short nascent chains (<48 resi-
dues; Sandikci et al., 2013). This poses a question as to how the 
interplay of these potentially competing factors is regulated. We 
therefore investigated how MetAP interacts with the ribosome 
and how its binding and function can be influenced by other 
factors. We show that NAC and Map1, like SRP, both contact 
the ribosome via Rpl25/35 and that NAC prevents antagonism 
between SRP and Map1 binding.
Results
Map1 interacts with the ribosome 
at the UAS
Both isoforms of MetAP (Map1 and Map2) were previously 
shown to be associated with the ribosome (Vetro and Chang, 
2002; Raue et al., 2007). However, the nature of this interaction 
in vivo was not addressed. We therefore investigated the ribo-
some interaction of the major yeast isoform, Map1. Ribosomes 
were isolated from cycloheximide-treated cells by centrifuga-
tion. The distribution of Map1 between the ribosome-enriched 
pellet and supernatant fractions was determined by SDS-PAGE 
and Western blot (Fig. 1 A). At physiological salt concentration 
(100 mM potassium acetate) quantitative association of Map1 
with ribosomes was observed. Upon treatment with higher salt 
concentrations (150–250 mM), a proportion of Map1 was re-
covered in the supernatant fraction. Above 300 mM, Map1 was 
recovered predominantly in the supernatant fraction, suggesting 
a salt-sensitive ionic interaction of Map1 with the ribosome.
We next assessed whether the nascent chain was neces-
sary to stabilize Map1 binding to the ribosome by using the 
conditional prt1-1 strain. This harbors a mutation in the β sub-
unit (p90) οϕ eIF3; upon shift to 37°C, translation initiation 
is blocked, leading to an accumulation of nonprogrammed 80S 
ribosomes lacking nascent chains (Fig. S1 A; Naranda et al., 
1994). The ribosome association of Map1 was almost identical 
when extracts from the prt1-1 mutant grown at 24°C or shifted 
to 37°C for 20 min were compared (Fig.  1  B). Furthermore, 
Map1 from both extracts exhibited a similar degree of salt-sen-
sitivity in the ribosome-binding assays (Fig. 1 C). Hence, Map1 
binding appears largely independent of the nascent chain.
We next assessed whether Map1 binds to the ribosome at 
the UAS. We made use of a yeast strain which expresses a C-ter-
minal Rpl25GFP fusion as the sole copy of Rpl25 (Hurt et al., 
1999). The rpl25GFP strain was previously shown to be com-
promised in ribosome binding of SRP and cotranslational target-
ing in vivo (Dalley et al., 2008). Ribosomes were isolated from 
cycloheximide-treated WT and rpl25GFP strains. A marked 
reduction in the association of Map1 with the ribosome was ob-
served in the rpl25GFP strain (Fig. 1 D). This was not a result of 
reduced overall levels of Map1 in these cells, as the rpl25GFP 
strain had total amounts of Map1 similar to WT (Fig. 1 D).
Next, total MetAP activity was measured in the three 
strains using a fluorescent peptide assay (Li et al., 2003). The 
Δmap1 control exhibited a statistically significant reduction in 
MetAP activity to ∼50% of WT levels (Fig. 1 E). Consistent 
with the reduction in ribosome binding, the rpl25GFP mutant 
showed a significant reduction in MetAP activity, although not 
as marked as in the Δmap1 mutant. To confirm these findings, 
shotgun MS/MS sequencing of proteins from the ribosomal 
fractions with masses around 25–27 kD obtained from the three 
strains was performed (Fig. S1 B). In the WT strain, methionine 
cleavage was efficient; we failed to detect any N termini with an 
intact methionine and a P2 residue, which was a substrate for 
MetAP cleavage (Table 1), In contrast, in the rpl25GFP strain, 
N-terminal peptides with an intact methionine were detected for 
Rpl16A, Rpl16B and Pex19. However, N-terminal processing 
was not affected for all proteins in this fraction; we failed to 
detect any unprocessed N-terminal peptides for the other pro-
teins, including Rpl7B and Rpl15A. Hence, Rpl16A, Rpl16B, 
and Pex19 may be particularly sensitive to the reduced level of 
Map1 at the ribosome in the rpl25GFP strain.
To directly address whether Map1 is bound at the UAS, 
chemical cross-linking was used to induce covalent linkages 
between ribosome-bound Map1 and any adjacent proteins. A 
C-terminally FLAG-tagged variant of Map1, which function-
ally complemented the strong growth defect of a Δmap1 strain 
was used (Fig. S2 A). Using the hetero-bifunctional cross-linker 
MBS, adducts of ribosome-associated Map1FLAG to partners of 
10, 12, 14, 20, and 25 kD were observed (Fig. 1 F). The 12-kD 
adduct is in good agreement with the size of Rpl35. Further-
more, an identically sized (58-kD) cross-link product, which 
cross-reacted with Rpl35 antibody, was specifically immunopre-
cipitated with anti-FLAG antibody (Fig. 1 F). When the cross-
link profile of Rpl35 for WT and Δmap1 ribosome fractions 
were compared, this 58-kD adduct was specifically absent in 
the Δmap1 strain, even on very long film exposures (Fig. S2 B).
Map1 and Map2 have distinct modes of 
interaction with the ribosome
Α Δmap1 strain is sensitive to the Map2 inhibitor fumagillin as 
it becomes reliant on Map2 for MetAP activity, unlike a MAP1 
strain, which is completely insensitive (Sin et al., 1997). We 
noticed that the rpl25GFP strain was retarded in growth in the 
presence of fumagillin (Fig. 2 A), suggesting, that it is depen-
dent on Map2. Hence, Map1 and Map2 may be differentially 
affected by the rpl25GFP fusion.
We therefore compared ribosome association of Map1 
and Map2, using an HA-tagged variant of Map2. Map2HA read-
ily associated with ribosomes in WT cells (Fig. 2 B). In con-
trast to Map1, Map2 binding was unaffected in the rpl25GFP 
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strain, and was slightly elevated in a Δmap1 strain (Fig. 2 B). 
To assess whether Map1 and Map2 have distinct ribosome 
binding modes, Map1 was overexpressed from the strong 
TDH3 promoter. This led to almost stoichiometric binding of 
Map1 to the ribosome as judged from the Coomassie staining 
of Map1 to a similar intensity as ribosomal proteins (Fig. 2 C). 
The cross-linking profile of ribosome-associated Map1 from 
this strain revealed identical sized adducts to those observed 
with Map1 at endogenous levels, including the cross-link to 
Rpl35 (Fig. S2 C), suggesting that overexpressed and endog-
enous Map1 interact similarly with the ribosome. Despite the 
dramatically elevated levels of Map1 on the ribosome, there 
was no reduction in Map2 binding (Fig. 2 C). Conversely, over-
expression of Map2 from the TDH3 promoter led to a dramatic 
increase in Map2 binding to the ribosome, without affecting 
Map1 binding (Fig. 2 D). Furthermore, Map1 and Map2 asso-
Figure 1. Association of Map1 with the ribosome at the UAS. (A) Extracts from WT cells (W303; T), were centrifuged through sucrose cushions at indicated 
salt concentrations to generate a ribosome-enriched pellet (P) and supernatant fraction (S). Fractions were analyzed by SDS-PAGE and blotting for Map1, 
Rpl17 (ribosome marker), and Zwf1 (cytosolic marker). (B and C) Ribosome pelleting analysis was performed as in A in the presence of 100 mM (B) or 
indicated salt concentrations (C) with prt1-1 (YMK135) cells grown either at 24°C or after a 20-min shift to 37°C followed by blotting for indicated proteins. 
(D) Ribosome pelleting was performed from WT (RS453), rpl25GFP and Δmap1 (GFY9) strains as in A. Pellets were analyzed by Western blot for Rpl25, 
Map1, and Zwf1 (loading control). (E) MetAP activity in total lysates from the indicated strains was determined using the fluorogenic substrate Met-AMC, 
as described in Materials and methods (error bars = SEM; n = 3). (F) Ribosome pellets from WT or a Δmap1::MAP1FLAG strain (GFY9::pMP289) were cross-
linked with 250 µM MBS, followed by denaturing immunoprecipitation with anti-FLAG or control (α-myc) antibodies. Total reactions and immunoprecipitates 
(IP) were analyzed by Western blot for FLAG or Rpl35. The Map1xRpl35 cross-link is indicated (o).
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ciated with ribosomes with differing salt sensitivities; Map2 
was still associated with the ribosome at 500 mM salt, whereas 
Map1 was predominantly in the supernatant fraction (Fig. 2 E). 
Collectively, these results indicate that Map1 and Map2 have 
distinct ribosome binding modes.
Map1 and NAC can bind simultaneously 
at the UAS
In addition to Rpl35, Map1 was cross-linked to two other pro-
teins of 20 and 25 kD (Fig. 1 F). In strains deleted of NAC, 
these two cross-links were absent suggesting they may corre-
spond to adducts between Map1 and NAC subunits (Fig. 3 A). 
The Rpl35 cross-link was also weaker, suggesting NAC may 
influence positioning of Map1 next to Rpl35. The 25-kD 
adduct corresponds to the size of αNAC (Egd2). To assess 
whether this was a cross-link between the two proteins, ri-
bosomes were prepared from WT, Map1-overexpressing, and 
Map1FLAG-expressing strains. Cross-linking with GMBS and 
blotting for Egd2 revealed, in addition to an Egd1 cross-link 
adduct, cross-links to a 43-kD adduct, in good agreement 
with the size of Map1 (Fig.  3  B). Moreover, this 43-kD ad-
Table 1. N-terminal peptides derived from 25–27 kD proteins from a 
ribosome-enriched fraction from WT (RS453, RPL25) and rpl25GFP cells 
(Fig. S1 B)
Protein N-terminal peptides
RPL25 (WT) rpl25GFP
Rpl7B Ac-STEKILTPESQLK
Rpl15A GAYKYLEELQR GAYKYLEELQR
Rpl16B Ac-SQPVVIDAK Ac-SQPVVIDAK
SQPVVIDAK SQPVVIDAK
MSQPVVIDAK
Rpl16A Ac-SVEPVVVIDGK Ac-SVEPVVVIDGK
SVEPVVVIDGK SVEPVVVIDGK
MSVEPVVVIDGK
Pex11 VCDTLVYHPSVTR VCDTLVYHPSVTR
MVCDTLVYHPSVTR
Figure 2. Map1 and Map2 have distinct interactions with the ribosome. (A) WT and Δrpl25 cells complemented with either a plasmid-borne RPL25 
(MPY69) or rpl25GFP (rpl25GFP) were spotted as serial dilutions onto YPD plates with or without 3 µM fumagillin and grown at 30°C for 2 d. (B) Ribo-
some pellets were prepared from WT (W303), and strains with C-terminally HA-tagged genomic MAP2 (MAP2HA) W303 (YNY5), rpl25GFP (YNY3), and 
Δmap1 (YNY4) and analyzed by Western blot for HA, Map1 and Rpl35. (C) Ribosome pellets from MAP2HA (YNY5) strain with or without Map1 over-
expression plasmid (pTDH-MAP1, pMP299) were analyzed by Western blot for Map2HA, Map1, and Rpl25. The ribosome pellets from WT with (+) and 
without (−) the pTDH-MAP1 plasmid were analyzed by SDS-PAGE and Coomassie staining. The position of the Map1 protein is indicated. (D) Ribosome 
pellets prepared and analyzed as in B from either WT (W303) or MAP2HA (YNY5) strain, transformed with pRS414 (vector) or pMP305 (pGPD-MAP2HA). 
(E) Ribosome pelleting from MAP2HA (YNY5) cell extract was performed in the presence of either 100 mM or 500 mM salt. Resulting total (T), supernatant 
(S), and pellet (P) fractions were analyzed by blotting for Rpl35, Map2HA, and Map1.
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duct was strongly elevated in the Map1 overexpression strain 
and also shifted upwards in the Map1FLAG strain (Fig.  3  B). 
Hence, when bound to the exit site, Map1 is positioned 
close to both Rpl35 and Egd2.
We also assessed whether Egd2 might be positioned 
close to Rpl35. Indeed, a 12-kD cross-link adduct to Egd2 was 
observed with the amine-reactive cross-linker DSS, and this 
was shifted upwards in a strain expressing HA-tagged Rpl35 
(Fig. 3 C). The identity of this adduct was confirmed by mass 
spectrometry of the cross-link product after denaturing im-
munoprecipitation with anti-HA resin (Fig. S2 D). Moreover, 
comparison of ribosome pellets of WT and rpl25GFP strains 
revealed a reduction in the levels of Egd2 (Fig. 3 D), thus con-
firming binding of Egd2 at the UAS.
NAC subunits contact proteins at either 
side of the ribosome exit site
Egd1 was shown to interact with the ribosome adjacent to 
Rpl31 (eL31), which is located on the opposite side of the 
exit site to Rpl35 (Pech et al., 2010; Zhang et al., 2012). 
To test if this interaction still occurred under the conditions 
when Egd2 is adjacent to Rpl35, ribosome fractions from an 
Egd1HA strain were cross-linked using DSS (Fig. S3 A) and 
cross-link adducts were isolated by denaturing immunopre-
cipitation using the anti-HA resin. Staining with Coomassie 
revealed cross-link partners of 10, 25, and 47 kD, which were 
identified by mass spectrometry as Rpl31, Egd2, and Zuo1, 
respectively (Fig. S3 B). The Rpl31 and Egd1 adduct is in 
excellent agreement with previous studies (Pech et al., 2010; 
Zhang et al., 2012) and Zuo1 is also known to bind to the 
ribosome close to Rpl31 (Peisker et al., 2008; Leidig et al., 
2013). Analysis of the cross-linked MS/MS spectra with 
MassMatrix (Xu and Freitas, 2009) identified a peptide corre-
sponding to a cross-link between Egd1 lysine 137 and Rpl31 
lysine 27 (Fig. S4 B). This maps to the surface-exposed re-
gion of Rpl31 (residues 23–41) previously implicated in Egd1 
binding (Pech et al., 2010).
Importantly, fusion of the HA-tag to Egd1, did not affect 
the formation of the Rpl35xEgd2 cross-link (Fig. S3 C). Thus, 
the previously reported Rpl31–Egd1 interaction could be repro-
Figure 3. Map1 is adjacent to NAC at the UAS. (A) Ribosome fractions derived from WT (BY4741) and Δnac strains were treated with the cross-linker 
GMBS (200 µM) and analyzed by Western blot for Map1. (B) Ribosome fractions from WT yeast (W303) with or without the pTDH-MAP1 plasmid 
(pMP299), as well a Δmap1 (GFY9) strain complemented with a Map1FLAG plasmid (pMP289), were treated with GMBS as in A and analyzed by 
Western blot for Egd2. (C) Cross-linking of ribosome fractions from WT (RPL35, W303) and a Δrpl35A/B strain expressing a C-terminally HA-tagged 
RPL35A (RBY175) were performed with DSS followed by Western blot for Egd2. (D) Ribosome pellets from indicated strains were analyzed by Western 
blot for Egd2, Rps3, and Rpl35.
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duced under conditions whereby Egd2 was detected to be adja-
cent to both Rpl35 and Map1 by chemical cross-linking.
Interplay of ribosome interaction of NAC, 
Map1, and SRP
Having established that NAC and Map1, just like SRP54, in-
teract with the ribosome at the UAS, we investigated whether 
they could influence one another’s ribosome binding. The ef-
fect of individually overexpressing NAC, Map1, or SRP on the 
ribosome association of each of the three factors was assessed 
in a WT strain. Overexpression of SRP led to increased ribo-
some binding of SRP, but did not alter ribosome-association of 
NAC or Map1 (Fig. 4 A). Overexpression of Map1 led to in-
creased ribosome binding of Map1 and a low level of Map1 in 
the supernatant, suggesting that binding was saturated. This had 
no effect on association of NAC with the ribosome, but led to 
reduced association of SRP with ribosomes, despite unaltered 
total cellular SRP levels (Fig. 4 A). Finally, overexpression of 
NAC led to a modest increase in association of Egd2 with the 
ribosome and a large pool of Egd2 in the supernatant with no 
effect on Map1 and SRP ribosome binding (Fig. 4 A).
Overexpression of SRP had a minimal effect on growth 
rate of a WT strain (Dalley et al., 2008), consistent with the 
fact that the ribosome association of NAC and Map1 is unaf-
fected (Fig.  4  A). We next investigated the effect of overex-
pressing SRP in Δmap1 and nac mutants. Overexpression of 
SRP in a Δmap1 strain had no effect on growth (Fig. S4 A). 
In contrast, Δegd1 mutant overexpressing SRP exhibited a 
marked reduction in growth, which was further enhanced in 
a Δegd1Δbtt1 mutant (Fig.  4 B). The Δegd2 mutant was also 
sensitive to SRP overexpression but to a lesser extent than the 
Δegd1 (Fig. 4 B and Fig. S4 B).
The association of Map1 in Δegd1 and Δegd2 was in-
vestigated using the ribosome-pelleting assay. Upon overex-
pression of SRP, Map1 was clearly detected in the supernatant 
fraction (Fig.  4 C). Consistent with this observation, reduced 
MetAP activity was detected in these mutants using the fluores-
cent peptide assay (Fig. S4 C).
The fact that in nac mutants, Map1 ribosome association 
was affected upon SRP overexpression led us to ask whether 
biogenesis of cytosolic proteins might be generally affected in 
such strains. We therefore investigated whether overexpression 
of SRP in these strains led to protein aggregation. Overexpres-
sion of SRP in a WT strain led to the accumulation of deter-
gent-insoluble aggregates, which were dramatically increased 
in the Δegd1 mutant (Fig. 4 D). The effect was less marked in a 
Δegd2 strain, consistent with the milder growth defect observed 
in this mutant. The pattern of aggregates observed in a Δegd1 
is similar to that for the Δssb1/2Δnac mutant (Fig. 4 D; Koplin 
et al., 2010), which was enriched in ribosomal and nuclear pro-
teins. Hence, in the absence of NAC, overexpression of SRP can 
interfere with the biogenesis of nonsecretory proteins.
Overexpression of SRP in the WT led to elevated SRP 
association with the ribosome (Fig. 4 A). However, a phenotype 
upon SRP overexpression was only observed in nac mutants. To 
assess whether the overexpressed SRP was bound to the ribo-
some in an altered manner in Δnac mutants, the cross-linking 
profile of ribosome-associated Sec65 subunit of SRP was inves-
tigated. Strikingly, a strong adduct of 53-kD was observed in WT 
and Δegd2 strains but was dramatically reduced in both Δegd1 
and Δegd1Δbtt1 strains, consistent with the stronger growth de-
fects upon SRP overexpression in these mutants (Fig. S4 D).
To investigate further the interplay of NAC and SRP, ri-
bosome association of SRP in a WT strain and nac mutants 
was compared. SRP association was markedly increased when 
EGD1 but not EGD2 was deleted (Fig. 4 E). This result sug-
gested that Egd1 is important in regulating SRP association 
with the ribosome. Consistent with this idea, overexpression of 
Egd1 was accompanied by a growth defect (Fig. S5 A) and a 
reduction in SRP association with the ribosome (Fig. S5 B). 
We also monitored cotranslational translocation using a PHO8-
URA3 reporter assay (Dalley et al., 2008). WT cells efficiently 
target Pho8–Ura3 to the ER and so cannot grow without uracil. 
Overexpression of Egd1, but not Egd2, led to growth without 
uracil, indicating a defect in translocation (Fig. S5 C).
NAC is involved in cotranslational 
translocation
Our data so far support the concept that NAC can prevent the 
inappropriate interaction of SRP with nonsecretory nascent 
chains. However, recent studies indicate that NAC can be found 
associated with a subset of secretory nascent chains (del Alamo 
et al., 2011) and can facilitate handover of secretory nascent 
chains to SRP in vitro (Zhang et al., 2012). We therefore revis-
ited any potential role for NAC in cotranslational ER targeting 
in vivo. It is already known that at 30°C, deletion of NAC sub-
units does not cause a translocation defect with the sensitive 
PHO8-URA3 reporter assay or with Dap2 in a pulse-labeling 
assay (Dalley et al., 2008; del Alamo et al., 2011). However, 
when translocation was tested with the PHO8-URA3 reporter 
at 16°C, a ura+ phenotype was detected for the Δegd2 mutant 
(Fig. 5 A). In contrast, there was no defect detected with a CPY-
URA3 reporter, which exclusively uses the Sec62-dependent 
targeting pathway (Fig. 5 B; Ng et al., 1996).
To further investigate the potential role of Egd2 in 
SRP-dependent translocation, we looked for a genetic interac-
tion between Δegd2 and a sec65-1 strain, which has a condi-
tional mutation in the Sec65 subunit of SRP. The sec65-1 strain 
grows well at 30°C (Fig. 5 C) but is not viable upon shift to 
37°C, where there is almost a complete block in SRP-dependent 
translocation (Stirling and Hewitt, 1992). At 30°C, the Δegd2 
mutant grew like the WT strain; however, the sec65-1Δegd2 
mutant revealed a marked growth defect (Fig. 5 C).
Using the PHO8-URA3 reporter, a marked transloca-
tion defect was observed in the sec65-1Δegd2 mutant at 30°C 
but not in the single mutants (Fig.  5  D). Analysis of total 
Sec65p levels in the WT, single and double mutants revealed 
that sec65-1 cells had lower total SRP levels as well as re-
duced association of SRP with the ribosome than WT, but 
this effect was not exacerbated in the sec65-1Δegd2 mutant. 
Hence, an indirect effect of egd2 deletion on SRP biogenesis 
can be excluded (Fig. 5 E).
As the presence of Egd2 appears to be important for Pho8 
translocation when SRP levels are reduced, we next asked 
whether elevating Egd2 levels might rescue translocation in a 
sec65-1 strain at 37°C. Pulse-labeling of Dap2 revealed an al-
most complete block in translocation in the sec65-1 strain after 
a shift to 37°C, with only the nonglycosylated precursor being 
detected (Fig. 5 F; Stirling and Hewitt, 1992). In contrast, over-
expression of either NAC or Egd2 alone was able to partially 
restore translocation after a shift to 37°C (Fig. 5 F).
Our observations suggest that Egd2 alone can provide 
a function in translocation at the ribosome and is positioned 
at the UAS. However, Egd1 has been proposed to provide 
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the major ribosome-binding site for NAC via Rpl31 (Pech et 
al., 2010; Zhang et al., 2012).
This led us to assess whether Egd2 can still associate with 
the ribosome in a Δegd1 strain. Although ribosome binding was 
reduced, residual binding of Egd2 was still observed. Chemical 
cross-linking revealed a 52-kD cross-link in this strain, which 
was also present in a WT strain, albeit at a much reduced level 
(Fig. S5 D). This cross-link is precisely the correct size for a 
homodimer of Egd2. Consistent with this, overexpression of 
Egd2 either alone or together with Egd1 led to elevated asso-
ciation of Egd2 with the ribosome and a marked increase in 
the 52-kD cross-link product (Fig.  5  G). Furthermore, under 
Figure 4. Interplay of ribosome binding of SRP, NAC, and Map1. (A) Ribosome pellets, supernatant, and total cell extracts from WT cells, or WT cells 
transformed with plasmids to overexpress NAC (pMP304), Map1 (pMP299), or SRP (pMW295 and pMW299) were analyzed by Western blot for Sec65, 
Egd2, Map1, and Rpl35. (B) Serial dilutions of WT strain and the indicated nac mutants transformed with SRP overexpression were spotted on −URA/LEU 
plates and grown at 30°C for 3 d. (C) Ribosomes from WT cells (BY4741), Δegd1 and Δegd2 transformed with plasmids overexpressing SRP were ana-
lyzed by Western blot for Map1 and Rpl35. (D) WT (BY4741), Δegd1 and Δegd2 strains transformed with SRP overexpression plasmids or empty vectors 
and Δssb1/ssb2Δnac (control) were grown in minimal medium to mid-log phase. Lysates were extracted with nonionic detergent to yield a pellet enriched 
in detergent-insoluble aggregates, which were analyzed by SDS-PAGE and Coomassie staining. The amount of aggregates were quantified (error bars = 
SEM; n = 3; **, P < 0.01; ***, P < 0.001 one-way ANOVA). (E) Ribosome pellets from WT (BY4741), Δbtt1, Δegd1, and Δegd2 cells were analyzed by 
SDS-PAGE and blotted for Sec65, Egd1, Egd2, and Rpl35.
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Figure 5. NAC mutants have mild SRP-dependent translocation defects. (A) WT (BY4741), Δegd1, Δegd2, Δbtt1, and rpl25GFP strains (control) were trans-
formed with a PHO8-URA3 reporter plasmid (pMP234) and streaked onto SD–leu (selects for plasmid) or SD–leu –ura media (selects for translocation defect) 
and grown for 7 d at 16°C. (B) Translocation assay was performed as in A, but with CPY-URA3. (C) WT (W303), sec65-1 (CSY128), Δegd2, and sec65-
1Δegd2 (YNY1) strains were grown to mid-log phase and serial dilutions spotted onto YPD media and grown at 30°C for 3 d. (D) PHO8-URA3 reporter assay 
was repeated as in A, but with strains as in C. (E) Total and ribosome fractions from cycloheximide-treated cells for strains as in C were analyzed by Western 
blot for Sec65, Rpl17, Egd1, and Egd2. (F) Dap2 translocation in WT (W303), sec65-1 (CSY128) cells, and sec65-1 cells overexpressing NAC (pMP304) or 
Egd2 (pMP302) was analyzed by pulse labeling. Nontranslocated (Dap2) and glycosylated (translocated) forms (g-Dap2) are indicated. (G) Ribosome pellets, 
prepared from WT and sec65-1 strains overexpressing Egd1, Egd2, or NAC were treated with DSS and analyzed by blotting for Egd2.
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native conditions a similarly sized band was readily detected 
in strains overexpressing Egd2 or NAC and, to a lesser extent, 
in WT or with Egd1 overexpression (Fig. S5 E), indicating that 
this putative Egd2 homodimer is stable in vivo. To confirm that 
this species is a homodimer, Egd2 was expressed and purified 
from Escherichia coli (Fig. S5 F). Cross-linking of the puri-
fied Egd2 with DSS led to the formation of an identical 52-kD 
cross-link adduct (Fig. S5 F).
EGD2 can prevent aggregation of SRP-
dependent translocation substrates
How might Egd2 be acting to rescue translocation in the absence 
of SRP? We speculated that in this situation, SRP substrates 
with hydrophobic signal sequences or signal anchors might be 
prone to aggregation. We therefore investigated whether the 
sec65-1 strain accumulates aggregates upon shift to 37°C. At 
24°C, WT cells, Δegd1, Δegd2, sec65-1, and sec65-1Δegd2 
mutants had very low levels of detergent-resistant aggregates 
(Fig. 6 A). In contrast, upon shift to 37°C, a marked increase 
in the aggregates was detected only in the sec65-1 and sec65-
1Δegd2 mutants (Fig. 6 A). To assess whether these aggregates 
included secretory precursors, Western blot analysis was used to 
investigate the presence of endogenous Pho8 in the aggregates 
of the sec65-1 strain. This was indeed the case, and the sec65-
1Δegd2 strain had a slightly higher level of Pho8 in aggregates 
(Fig. 6 A). To confirm that the Pho8 detected corresponded to 
the untranslocated form of the protein, extracts from WT and 
sec65-1 cells shifted to 37°C were analyzed by Western blotting 
for Pho8 (Fig. 6 B). WT total cell extract revealed a single band 
of Pho8, which was sensitive to PNGase F treatment, indicat-
ing that it was N-glycosylated. The sec65-1 total cell extract 
revealed a single Pho8 band insensitive to PNGase F treatment, 
indicating that it was non glycosylated. The detergent-insoluble 
fraction from WT cells lacked Pho8, whereas the same fraction 
from sec65-1 cells contained the PNGase-insensitive species as 
in the sec65-1 total cell extract, thus, confirming that the aggre-
gates contain unglycosylated Pho8.
To assess whether these aggregates represented newly 
synthesized proteins, detergent-insoluble fractions were pre-
pared from the WT, sec65-1, and sec65-1Δegd2 strains after 
pulse labeling with [35S] methionine and cysteine (Fig.  6  C). 
WT cells exhibited a very low level of aggregation of radiola-
beled newly synthesized proteins in contrast to sec65-1, which 
showed a higher level of aggregation that was further increased 
in the sec65-1Δegd2 strain. Thus, the aggregates in the two mu-
tant strains indeed contain newly synthesized protein.
To test if overexpression of Egd2 can suppress aggrega-
tion in the sec65-1 strain and thereby preserve the transloca-
tion competence of SRP-dependent precursors, pulse labeling 
was repeated in the sec65-1 strain overexpressing Egd2. A 
marked reduction in aggregation of newly synthesized pro-
teins was observed (Fig. 6 C).
Based on this result, total protein aggregates were exam-
ined in sec65-1 strains overexpressing either NAC or Egd2 from 
low copy or multicopy plasmids. Consistent with the pulse-la-
beling result, there was a dramatic reduction of aggregated 
Pho8 upon expression of either NAC or Egd2 from low copy 
plasmids which was further reduced with high copy plasmids 
(Fig. 6 D). Overexpression of either NAC or Egd2 also led to a 
modest reduction in total aggregated protein.
We noticed that the Pho8 Western blot analysis of the ag-
gregates revealed higher molecular weight species, which is con-
sistent with ubiquitination (Fig. 6 D). Western blot for ubiquitin 
in the aggregates confirmed a smear of ubiquitinated products, 
which increased in the sec65-1Δegd2 strain and was reduced 
upon expression of Egd2 in the sec65-1 strain (Fig. 6 E).
Discussion
Map1 is the major isoform of the yeast MetAP. Here, we have 
shown that when bound to the ribosome, Map1 can be cross-
linked to Rpl35. Consistent with this, ribosome-association of 
Map1 is disrupted by fusion of GFP to Rpl25, which likely ste-
rically hinders access to the UAS, leading to defects in methi-
onine-processing of a subset of cytosolic proteins. We observed 
a reduction in MetAP activity upon loss of Map1 ribosome 
association, suggesting that ribosomes may influence the spe-
cific-activity of Map1. The positioning of Map1 at the exit site 
would allow cotranslational processing of the N-terminal me-
thionine as soon as it emerges from the exit site, consistent with 
previous studies (Jackson and Hunter, 1970). Association of the 
bacterial MetAP with the ribosome was recently characterized 
(Sandikci et al., 2013); strikingly, E.  coli MetAP could also 
be cross-linked to the bacterial homologue of Rpl25 (uL23), 
as well as bacterial ribosomal protein bL17, which lacks a 
direct eukaryotic homologue.
Map1 and Map2 appear to have nonoverlapping ribosome 
binding sites, indicated by the fact that (a) overexpression of 
Map1 led to quantitative ribosome binding with no effect on Map2 
association, (b) overexpression of Map2 similarly had no effect 
on ribosome binding of Map1, and (c) the rpl25GFP fusion dis-
rupted Map1 binding to the ribosome, but had no effect on Map2.
When bound to the ribosome, Map1 is adjacent to Egd2, 
and both proteins are close to Rpl35. The fact that we readily 
detected cross-links between the two proteins indicates that they 
can bind simultaneously to ribosomes in vivo. Moreover, over-
expression of Map1 led to almost stoichiometric occupancy of 
ribosomes with Map1, with no effect on ribosome association 
of Egd2 or Egd1. We also detected a cross-link adduct of ∼20 
kD to Map1, which was absent in the nac mutants. This likely 
represents a cross-link between Map1 and Egd1. Hence, NAC 
and Map1 can sit together on the ribosome adjacent to the UAS.
Egd1 was shown to interact with the ribosome via Rpl31 
(Pech et al., 2010; Zhang et al., 2012), which is located oppo-
site to Rpl25/35 at the exit site. We also detected cross-links 
between Egd1 and Rpl31 indicating that Egd2 is adjacent to 
Rpl35, whereas Egd1 is next to Rpl31. Thus, our data are con-
sistent with previous studies demonstrating interaction at both 
sites (Wegrzyn et al., 2006; Pech et al., 2010; Zhang et al., 
2012). Interestingly, cross-links were detected between Egd1 
and Zuo1, which also associates with the ribosome close to 
Rpl31 (Peisker et al., 2008; Leidig et al., 2013), thereby sug-
gesting that ribosomes can bind NAC and the ribosome–associ-
ated complex (RAC) simultaneously.
In contrast to NAC and Map1, which can bind simul-
taneously to the ribosome, SRP antagonizes ribosome bind-
ing of Map1 in the absence of NAC. Ribosomes with both 
Map1 and NAC bound (upon Map1 overexpression) had 
reduced interaction with SRP. Overexpression of SRP was 
tolerated in the presence of NAC, but not NAC deletions, in 
particular the egd1 mutant, exhibited growth defects upon 
overexpression of SRP, which correlated with reduced associ-
ation of Map1 with the ribosome.
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Figure 6. Egd2 prevents aggregation of nontranslocated SRP-dependent precursors. (A) WT (W303), Δegd1, Δegd2, sec65-1 (CSY128), and sec65-
1Δegd2 (YNY1) strains were grown in YP media at 24°C or shifted to 37°C for 120 min to mid log phase. Lysates were extracted with nonionic detergent 
to yield a pellet enriched in detergent-insoluble aggregates, and analyzed by SDS-PAGE and Coomassie staining or blotting for Pho8. The total amount 
of aggregates quantified (error bars = SEM; n = 3; *, P < 0.05; **, P < 0.01 one-way ANOVA). (B) WT (W303) and sec65-1 (CSY128) strains were 
grown in YP media to mid-log phase and shifted to 37°C, and aggregates were isolated as in A. Where indicated, extracts were treated with PNGase F.  
Reactions were analyzed by blotting for Pho8. Position of nonglycosylated (pPho8p) and glycosylated Pho8 (g-Pho8p) is indicated. (C) WT (W303), 
sec65-1 (CSY128), and sec65-1Δegd2 (YNY1) cells were grown to mid-log phase in minimal media at 30°C and then pulse-labeled with [35S] methionine 
and cysteine for 5 min before analysis as in A but with SDS-PAGE and phosphorimaging. (D) WT (W303) and sec65-1 (CSY128) harboring CEN or 
2 µm plasmids for expressing EGD1 (pMP300), EGD2 (pMP301 or pMP302), or NAC (EGD1 and EGD2 -pMP303 and pMP304) were analyzed for 
aggregates as in A. (E) Aggregates from WT, sec65-1 (CSY128), sec65-1Δegd2 (YNY1) and sec65-1 with a CEN EGD2 plasmid (pMP301) strains were 
analyzed by blotting for ubiquitin.
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In WT cells, both ribosomes and NAC are present in large 
excess over SRP and Map1 (Raue et al., 2007), hence it is un-
likely that SRP and Map1 are simultaneously bound to the same 
ribosome. This would explain why the absence of NAC has a 
minimal effect on growth, as the antagonistic effect of SRP on 
ribosome association of Map1 is limited because of the rela-
tively low concentration of SRP.
The structure of the eukaryotic SRP bound to a secretory 
RNC indicates multiple contact points, the strongest of which is 
centered upon Rpl25/35, as well as nearby helix 59 and helix 24 
of the rRNA (Halic et al., 2004). We now show that both Map1 
and Egd2 can be simultaneously adjacent to Rpl25/35, hence it 
is perhaps not surprising that all three ligands cannot be accom-
modated at this site. Consistent with this idea, signal sequences 
are rarely substrates for Map1 processing (Forte et al., 2011; 
Sandikci et al., 2013) and N-terminal processing was compro-
mised for an SRP-dependent signal sequence (Forte et al., 2011).
Overexpression of SRP in the Δegd1 strain led to the ac-
cumulation of detergent-insoluble aggregates, which are remi-
niscent of those observed in a Δssb1/2Δnac mutant (Koplin et 
al., 2010). A previous study showed that Δnac mutants display 
a promiscuous interaction of SRP with cytosolic nascent chains 
(del Alamo et al., 2011). Our data suggests that in the absence 
of NAC, SRP interacts with such nascent chains and can inter-
fere with their biogenesis. SRP and Ssb1/2 were recently shown 
to interact with distinct nascent chain clients (Willmund et al., 
2013). Hence, it is likely that in the absence of NAC, SRP in-
terferes with Ssb1/2 function, leading to cytosolic protein ag-
gregation. This is entirely consistent with the close match in 
aggregation profile observed in Δssb1/2Δnac and nac mutants 
overexpressing SRP shown in this study. We detected the stron-
gest phenotype upon SRP overexpression in the Δegd1 mutant, 
consistent with the previous observation that Egd1 preferentially 
associates with cytoplasmic proteins (del Alamo et al., 2011).
We revisited the role of NAC in cotranslational transloca-
tion and find that at 16°C, or when SRP levels are limiting as 
in a sec65-1 mutant, translocation of Pho8 is inefficient when 
NAC is compromised. These defects appear to be specifically 
linked to the Egd2 subunit, as Δegd2 mutants show SRP-depen-
dent, but not Sec62-dependent translocation defects, whereas 
Δegd1 cells have no defect in either pathway.
SRP levels are greatly substoichiometric to ribosomes 
(Raue et al., 2007), and this is further exacerbated in the sec65-1 
cells. Under these conditions, the time window before signal 
sequence recognition can occur is likely to be extended. If un-
checked, this would increase the likelihood of SRP-dependent 
substrates aggregating as they are intrinsically hydrophobic. 
Hence, a potential function for Egd2 would be to prevent aggre-
gation before signal sequence recognition. Entirely consistent 
with this hypothesis, sec65-1 strains accumulate detergent-in-
soluble aggregates of newly synthesized proteins, including 
the SRP-dependent precursor Pho8, and this is exacerbated by 
simultaneous deletion of Egd2. In contrast, overexpression of 
Egd2 reduces aggregation of Pho8 and partially rescues translo-
cation of SRP-dependent precursors.
These observations are consistent with the recent results 
observed in C.  elegans, identifying a chaperone function for 
NAC (Kirstein-Miles et al., 2013). The aggregates observed 
in the sec65-1 were ubiquitinated, and this was reduced upon 
expression of Egd2. This correlates with a previous study that 
showed that NAC protects nascent chains from cotranslational 
ubiquitination (Duttler et al., 2013).
NAC was previously shown to exist predominantly as a 
heterodimer of Egd2 and Egd1 (Reimann et al., 1999). How-
ever, the αNAC homologue from archaea forms a homodimer 
(Spreter et al., 2005). Moreover, studies in yeast showed that 
Egd2 alone, specifically associates with secretory nascent 
chains, consistent with a role for the Egd2 homodimer in the 
biogenesis of secretory proteins (del Alamo et al., 2011).
In the absence of Egd1, Egd2 associated with the ri-
bosome, albeit at a reduced level and resulted in a 52-kD 
adduct upon cross-linking, which is entirely consistent with 
the size of an Egd2 homodimer. Furthermore, this cross-link 
was increased upon Egd2 overexpression and was also de-
tected with purified Egd2. The Egd2 homodimer was also de-
tected under native conditions, suggesting that separate pools 
of homo- and heterodimers are associated with ribosomes 
in vivo. The presence of native Egd2 complexes in the size 
range of 48 to 68 kD (Reimann et al., 1999) in the Δegd1 
strain is also in agreement with the presence of an Egd2 ho-
modimer. However, previous studies suggested that Egd2 is 
less likely to homodimerize in the presence of Egd1 (Spreter 
et al., 2005). Consistent with this, levels of the homodimer 
were very low in the WT strain.
Collectively, our data indicate that NAC modulates the 
interaction of SRP with the ribosome, as suggested previously 
(Powers and Walter, 1996), and this in turn influences binding 
of additional ligands such as Map1. In the presence of NAC, 
SRP can bind to the ribosome such that Map1 can also be ac-
commodated (Fig. 7). The fact that SRP makes multiple con-
tacts with ribosome (six in the case of canine SRP; Halic et 
al., 2004) may permit an initial low-affinity binding confor-
mation that utilizes only a subset of these contacts. This con-
formation would be compatible with the presence of NAC and 
other ligands such as Map1.
Secretory chains first contact NAC, and then subsequently 
SRP54 (Wiedmann et al., 1994; Jungnickel and Rapoport, 1995; 
Zhang et al., 2012), hence NAC may act to preserve a "sampling 
mode" whereby multiple factors can bind the ribosome simul-
taneously (Holtkamp et al., 2012). This would allow Map1 to 
bind and process N termini as well as permitting sampling of 
the nascent chain by SRP. Subsequent signal sequence-recog-
nition by SRP would then lead to the release of NAC (Fig. 7), 
permitting SRP to make extensive ribosome contacts (Zhang et 
al., 2012), which are no longer compatible with Map1 binding. 
These two modes of interaction of SRP with the ribosome are 
consistent with the changes in the Sec65 cross-linking profile 
observed when SRP is overexpressed in strains lacking βΝΑC 
as compared with WT strain.
The presence of a signal sequence inside the ribosome 
exit tunnel was shown to increase the affinity of SRP for ribo-
somes (Berndt et al., 2009). This may occur by subtly altering 
the arrangement of the ribosome and/or NAC at the exit site 
such that SRP binding is more favored. This might then facili-
tate more efficient delivery of the signal sequence to SRP. It is 
conceivable that these changes could favor binding of the Egd2 
homodimer over the Egd1/Egd2 heterodimer.
Our data suggest Egd2 can prevent aggregation of se-
cretory nascent chains when SRP is at reduced levels. In the 
absence of SRP, in vitro studies show that probes within the 
signal sequence of RNC readily cross-link to NAC (Jung-
nickel and Rapoport, 1995). Hence in the sampling mode, 
NAC may also function to prevent aggregation of the signal se-
quence before SRP’s arrival.
o
n
 June 19, 2017
D
ow
nloaded from
 
Published July 20, 2015
JCB • Volume 210 • NumBer 2 • 2015298
Materials and methods
Yeast strains, culture, and genetic manipulation
Yeast strains were grown either in YPD (rich) media (1% [wt/vol] yeast 
extract, 2% [wt/vol] peptone, and 2% [wt/vol] glucose) or minimal 
media (0.67% [wt/vol] yeast nitrogen base and 2% [wt/vol] glucose) 
plus appropriate amino acids supplements. All yeast strains were cul-
tured at 30°C, unless otherwise specified. Standard yeast protocols 
were used for transformations (Guthrie and Fink, 1991).
S.  cerevisiae strains used in this study are listed in Table S1. 
Unless indicated otherwise, the WT and single knockout strains were 
obtained from the BY4741 series of the EUROSCARF strain collection 
(Winzeler et al., 1999). Double-deletion strains were constructed by 
mating, diploid sporulation, and dissection of haploids as previously 
described (Guthrie and Fink, 1991). YNY1 was constructed by mating 
Δegd2 and sec65-1 strains and YNY2 was constructed by mating Δegd1 
and Δbtt1. In brief, diploid yeast strains were constructed by mixing 
haploid strains of opposite mating types on YPD solid medium. After in-
cubating overnight, diploids were positively selected on YNB solid me-
dium using appropriate auxotrophic markers. Diploid strains were grown 
to stationary phase at 30°C, in presporulation medium (0.8% [wt/vol] 
yeast extract, 0.3% [wt/vol] Bacto-peptone) supplemented with 10% 
(wt/vol) glucose after autoclaving. Cells were washed with sterile ddH2O 
and resuspended in 10 ml of sporulation medium (1% [wt/vol] potassium 
acetate, 0.1% [wt/vol] Yeast extract) containing appropriate amino acid 
and supplements at a final concentration of 0.002% (wt/vol) and 0.05% 
(wt/vol) glucose. Sporulation was allowed to proceed by growing at 
24°C for 3–4 d, after which the efficiency of sporulation was monitored 
microscopically. Once sufficient sporulation had occurred, 10 µl of cells 
were diluted with 190 µl of ddH2O and treated with 5 units of Zymolyase 
T100 (AMS Biotechnology Ltd) for 5 min. Next, 10 µl of the treated 
spores were run vertically down a YPD solid medium plate and allowed 
to dry. A Narishige micro-manipulator microscope was used to separate 
the four spores from each ascus. This was performed upon a minimum of 
10 complete tetrads. Spores were allowed to grow on YPD solid medium 
at 30°C for 2–3 d. Haploid progeny of dissections were tested for gene 
deletion by the presence of G418-Geneticin cassette, growth at 37°C, 
and Western blotting for absence of different NAC subunits.
RS453, RPL25GFP, and Δmap1 (GFY9) strains were C-termi-
nally tagged with 3x HA at the MAP2 locus using a cassette ampli-
fied from the pYM24 (using gene-specific primers; Table S2), which 
confers resistance to the antibiotic Hygromycin B to the transformed 
yeast (Janke et al., 2004). The HA-tagging was confirmed by both 
PCR and Western blot analysis.
Plasmid construction
Plasmids used in this study are listed in Table S3, and the primers for 
constructing plasmids and strains are listed in Table S2. Plasmids con-
struction was performed using standard molecular biology techniques.
The MAP1 ORF, ∼1,400 bp including 500 bp of 5′ sequence, 
was amplified from genomic DNA using primers Map1FLAGF and 
Map1 FLAGR and then ligated into pMP220 (Dalley et al., 2008) cut 
with SalI and PstI. The resulting plasmid, pMP289, drives Map1FLAG 
expression under its own endogenous promoter and the NUF2 3′UTR. 
To generate the plasmid for overexpressing Map1 under the high copy 
glyceraldehyde-3-phosphate dehydrogenase promoter, the entire ORF 
was amplified by PCR from yeast genomic DNA using primers Map1F 
and Map1R, which include flanking BamHI and EcoRI sites, respec-
tively. The resulting ∼1,164-bp fragment was digested with these same 
enzymes and ligated into BamHI and EcoRI digested pRS414-GPD 
(Mumberg et al., 1995). The resulting plasmid, pMP299, encodes the 
complete MAP1 ORF expressed from the strong GPD promoter.
The Map2 open reading frame was amplified from genomic 
DNA with primers Map2HAF and Map2HAR, which add a C-ter-
minal triple-HA tag and flanking BamHI and EcoRI sites. The 
resulting fragment was then cloned into pRS414GPD via these re-
striction sites to give pMP305.
To generate the plasmid for overexpressing Egd1, the entire ORF 
was amplified by PCR from yeast genomic DNA using primers EGD1F 
and EGD1R that include flanking PstI and NotI sites, respectively. The 
resulting ∼1,480-bp fragment was digested with these same enzymes 
and ligated into PstI and NotI digested pRS422 (2μ) vector (Sikorski 
and Hieter, 1989). The resulting plasmid, pMP300, encodes the com-
plete EGD1 under the control of the endogenous promoter. To generate 
the plasmid for overexpressing Egd2, the entire EGD2 ORF was am-
plified by PCR from yeast genomic DNA using primers EGD2F and 
Figure 7. Model indicating a novel role for NAC in reg-
ulating the access of MAP and SRP to the ribosome. Short 
nascent chains first encounter NAC, which interacts with 
the ribosome close to Rpl25/35 and Rpl31/17 (1). The 
presence of NAC allows both SRP and Map1 to bind the 
ribosome and sample nascent chains (2). The presence of 
an SRP substrate changes the conformation of NAC, pos-
sibly in response to a signal sequence/anchor in the exit 
tunnel such that SRP can bind the signal sequence (3). The 
α subunit of NAC can prevent aggregation of the signal 
sequence before the arrival of SRP. Handover of the signal 
sequence to SRP releases NAC leading to tight binding 
of SRP (4). Nonsecretory proteins interact with RAC and 
Ssb1/2 as the nascent chain extends (5). In the absence of 
NAC, SRP binding precludes Map1 binding thereby com-
promising processing and folding of cytosolic proteins.
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EGD2R, which included flanking SalI and PstI sites, respectively. The 
resulting ∼975-bp fragment was digested with these same enzymes and 
ligated into SalI and PstI sites digested pRS412 (CEN) and pRS422 
(2μ) vectors (Sikorski and Hieter, 1989), yielding plasmids, pMP301 
and pMP302, respectively. To generate the plasmid for overexpressing 
NAC, the PCR products for EGD1 and EGD2 were digested as de-
scribed above and were both cloned into the same vector pRS412 (CEN) 
and pRS422 (2μ) to give plasmids pMP304 and pMP303, respectively. 
To overexpress Egd2 in E. coli with a cleavable N-terminal his-tag, the 
EGD2 ORF was amplified from pMP301 using primers EGD2pET28F 
and EGD2pET28R, which include flanking NdeI and BamHI sites and 
was ligated into pET28 digested with NdeI and BamHI to yield pMP306.
Subcellular fractionation: ribosome pelleting
Yeast cells were grown in complete media to an OD600 of ∼0.6, and 
then treated with 0.1 mg/ml cycloheximide for 10 min. Cells were 
resuspended in lysis buffer (100  mM KOAc, 20  mM Hepes-KOH, 
5 mM Mg[OAc]2, 4 mM DTT, 0.1 mg/ml cycloheximide, 1 mM PMSF, 
and Roche protease inhibitors) and broken by glass bead lysis and 
resulting cells lysates cleared of cellular debris by centrifugation at 
1,200 g. Membranes were solubilized by the addition of 1% (wt/vol) 
CHAPS, in the presence of 100 mM KOAc (low salt) or variable salt 
concentrations as indicated up to 500 mM KOAc (high salt). Insoluble 
material was removed by centrifugation for 20 min at 16,000 g. The 
resulting supernatant was centrifuged for 1 h at 256,000 g, through a 
500-mM sucrose cushion in lysis buffer, to generate a ribosome-en-
riched pellet and post-ribosomal supernatant.
Polysome analysis
To fractionate the polyribosomes, 5 OD260nm units of lysate were ap-
plied to the top of a 13-ml linear 10–55% (wt/vol) sucrose gradient 
in lysis buffer and centrifuged for 150 min at 285,000 g at 4°C in a 
SW40 rotor (Beckman). Gradients were fractionated using ISCO 
gradient fractionator with continuous monitoring of A260nm to detect 
monosomes and polysome peaks.
Mass spectrometry
Coomassie-stained bands were excised from gels, reduced, and then 
alkylated before digestion with trypsin. Digested samples were ana-
lyzed by LC-MS/MS using a NanoAcquity LC (Waters) coupled to a 
LTQ Velos (Thermo Fisher Scientific). Peptides were concentrated on 
a precolumn (20 mm × 180 µm i.d., Waters), and then separated using 
a gradient from 99% A (0.1% [vol/vol] formic acid in water) and 1% B 
(0.1% (vol/vol) formic acid in acetonitrile) to 30% B, in 40 min at 300 
nl/min−1, using a 75 mm × 250 µm i.d. 1.7 µM BEH C18, analytical col-
umn (Waters). Peptides were selected for fragmentation automatically 
by data-dependent analysis.
Chemical cross-linking
Ribosome-enriched pellet fractions were resuspended in lysis buffer 
(100 mM KOAc; in the absence of DTT when using MBS and GMBS) 
at a concentration of 32 OD260/ml and incubated with DSS, MBS, or 
GMBS at a final concentration of 100–500 µM (prepared as a 20 mM 
stock in DMSO) for 10 min at 25°C before quenching with 10 mM 
glycine pH 7.5/10 mM 2-mercaptoethanol.
In vivo pulse-labeling and denaturing immunoprecipitation
WT or knockout yeast cells were grown in YNB medium with appro-
priate supplements to an OD600 of ∼0.2. Where indicated, cells were 
grown in the presence of 10 µg/ml tunicamycin (Merck) for 90 min 
before labeling. Pulse-labeling was initiated by addition of 10 µCi of 
[35S] methionine/cysteine cell labeling mix (Perkin-Elmer) per OD600nm 
units of cells for 5–10 min at 30°C (20 min at 16°C). Labeling was ter-
minated by addition of ice cold sodium azide to a final concentration of 
20 mM. For each sample, 10 OD600nm units of cells were harvested. Ra-
diolabeled yeast cells were then spheroplasted with Zymolyase 100T 
(AMS Biotechnology) before addition of lysis buffer (1% SDS, 50 mM 
Tris-HCl, pH 7.4, and 5 mM EDTA), and then incubated at 95°C for 5 
min. Samples were then diluted with 5 volumes of immunoprecipita-
tion buffer (62.5 mM Tris-HCl, pH 7.4, 1.25% (vol/vol) Triton X-100, 
190 mM NaCl, and 6.25 mM EDTA), precleared with protein A beads 
for 1 h, and then anti-Dap2 antisera added to the supernatant. After 1 h, 
immune complexes were recovered by adding protein A Sepharose and 
incubating for another hour, followed by washing three times before 
elution with SDS-PAGE sample buffer. Samples were analyzed by SDS-
PAGE and visualized by phosphorimaging. In the case of unlabeled 
cells the same protocol was used following cross-linking and anti-HA 
(Roche) or FLAG resins (Sigma) were used for immunoprecipitation
Isolation of aggregated proteins
Isolation of aggregated proteins from yeast mutants was performed as 
previously described (Koplin et al., 2010). In brief, cells were grown to 
0.6 OD600 units in minimal medium with appropriate selection. Cells 
were harvested, and resulting cell pellets were resuspended in lysis buf-
fer (20 mM Na-phosphate, pH 6.8, 10 mM DTT, 1 mM EDTA, 0.1% 
[vol/vol] Tween 20, 1 mM PMSF, protease inhibitor cocktail [Roche], 
3 mg/ml zymolyase 100T, and 1.25 U/ml benzonase) and incubated 
at room temperature for 20 min. Chilled samples were treated by tip 
sonication and centrifuged for 20 min at 200 g at 4°C. Supernatants 
were adjusted to same OD280nm, and aggregated proteins were pelleted 
at 16,000  g for 20 min at 4°C.  After removing supernatants, aggre-
gated proteins were washed twice with 2% (vol/vol) NP-40 (in 20 mM 
Na-phosphate, pH 6.8, 1  mM PMSF, and protease inhibitor cock-
tail), sonicated again, and centrifuged again at 16,000 g for 20 min at 
4°C. Aggregated proteins were washed in NP-40–deficient buffer, son-
icated, boiled in SDS sample buffer, separated by SDS-PAGE (14%), 
and analyzed by Coomassie staining.
PNGase F treatment
Deglycosylation of protein was performed by digesting isolated aggre-
gates or precleared lysates with PNGase F. In brief, isolated aggregates 
or total lysate were solubilized in 1X Glycoprotein Denaturing Buf-
fer (New England Biolabs) in a 10 µl total reaction volume. Samples 
were denatured by heating the reaction mix to 100°C for 10 min. Next, 
2  µl of 10× G7 Reaction Buffer, 2  µl of 10% (vol/vol) NP-40, 2  µl 
PNGase F (New England Biolabs), and 4 µl of water were added. The 
reaction was incubated at 37°C for 1 h. Analysis was carried out by 
SDS-PAGE and Western blotting.
Translocation reporter assays
To monitor translocation, PHO8-URA3 (cotranslational) and CPY-
URA3 (posttranslational) reporter-based assays were performed as 
described previously (Dalley et al., 2008). In brief, yeast cells trans-
formed with reporter plasmids pMP234 (PHO8-URA3) and pMR12 
(CPY-URA3) were streaked in parallel on minimal media plates lacking 
either leucine alone or both uracil and leucine, and then grown at either 
16°C or 30°C for 2–5 d. Growth in the absence of uracil is indicative 
of a defect in translocation.
MetAP enzymatic assay
The methionine aminopeptidase activity of total cell lysates was mon-
itored by using the fluorescent based assay as previously described 
(Li et al., 2003). Extracts were prepared in a buffer containing 50 mM 
MOPS, pH 7.0, 5 mM Mg(OAc)2, and 5 mM CoCl2 as the divalent cat-
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ion. The reaction was initiated by the addition of 100 µM Met-AMC. 
The cleavage of the Met from Met-AMC (I-1265.0250; Bachem) was 
monitored by measuring the release of AMC by fluorescence spectros-
copy (Em wavelength of 460 nm with Ex wavelength at 360 nm).
Protein expression
The His-tagged Egd2 protein was expressed in E. coli BL21(DE3) and 
purified via nickel-nitrilotriacetic acid-agarose (QIAGEN; according to 
the manufacturer's manual). The His tag was removed from Egd2 by 
thrombin cleavage during the purification procedure.
Image acquisition
Radioactive gels were imaged using a Typhoon FLA-7000 phosphorim-
ager (GE Healthcare) and subsequently processed using Aida software 
(Raytest). ECL films (BioMX MR; Kodak), Coomassie-stained gels 
and plates were scanned with an Epson Perfection V700 using Image 
Capture (Apple) or Adobe Photoshop software. Coomassie-stained 
gels were quantified using Aida (Raytest). Statistical analysis was per-
formed with GraphPad (Prism).
Antibodies
Anti-myc (mouse, 4A6) was obtained from Upstate; anti-HA (mouse, 
HA-7), anti-FLAG M2 (mouse), and anti-Zwf1p (rabbit) were pur-
chased from Sigma-Aldrich; and Pho8 antibody (mouse, 1D3A10) was 
purchased from Life Technologies. Antibodies against Rps3p (rabbit, 
peptide VALISKKRKLVADCCONH2), Rpl35p (rabbit, peptide CPIRK-
YAIKVCOOH), Rpl25p, DPAP B, CPY, Sec65p, Egd1p, and Egd2p 
have been described previously (Stirling et al., 1992; Ogg et al., 1998; 
Mason et al., 2000; Frey et al., 2001; Panasenko et al., 2006) Antibod-
ies to Map1 and Rpl17 were raised in rabbits (Cambridge Research 
Biochemicals) against the epitopes CARNKKSPGGPRQRIK-COOH and 
[C]-Ahx-QVNQAPKQRRRTYR-CONH2, respectively.
Online supplemental material
Table S1 shows yeast strains. Table S2 shows primers used in the study. 
Table S3 lists plasmids used in the study. Fig. S1 shows analysis of 
ribosomes from prt1-1 and rpl25GFP strains. Fig. S2 shows that Map1 
and Egd2 are both adjacent to Rpl35 when bound to the ribosome. Fig. 
S3 shows cross-link analysis of ribosome-associated Egd1 and Egd2. 
Fig. S4 shows that overexpression of SRP in egd1 and egd2 mutant 
strains retards growth and reduces MetAP activity. Fig. S5 shows that 
overexpression of Egd1 and Egd2 leads to distinct SRP-dependent 
translocation phenotypes. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201410086/DC1.
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